Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Согласно настоящему изобретению предложены композиции, способы и варианты применения, включающие (i) биспецифические связывающие агенты, которые специфически связываются с раковым антигеном, (ii) агенты для выведения и (iii) радиотерапевтические агенты для лечения рака. Также согласно настоящему изобретению предложены варианты применения и способы лечения связанных с HER2 видов рака.The present invention provides compositions, methods, and uses comprising (i) bispecific binding agents that specifically bind to a cancer antigen, (ii) agents for excretion, and (iii) radiotherapeutic agents for treating cancer. The present invention also provides uses and methods for treating HER2-associated cancers.
EA202091978A2019-03-042019-03-11
SPECIFIC BINDING AGENTS AND THEIR APPLICATIONS
EA202091978A1
(en)
STABILITIES OF ANTI-CTLA4 ANTIBODIES, SEPARATELY AND IN COMBINATION WITH ANTIBODIES AGAINST PROGRAMMED DEATH RECEPTOR 1 (PD-1), AND METHODS OF APPLICATION